Clinical Trials on Macular Hole Retinal Detachment in Belgium

Total 87 results

Universitaire Ziekenhuizen KU Leuven

Recruiting

Zeiss RESIGHT Disposable Lenses Evaluation Study (RESIGHT)

Retinal Detachment | Macular Holes | Vitreomacular Traction | Macular Pucker

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Efficacy and Safety Evaluation of MONOBLUE DUAL View and MONOBLUE ILM View Vital Stains (NewBlueDyes)

Macular Holes | Vitreomacular Traction | Macular Pucker

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Vitreopapillary Interface and Optic Disc Morphology

Glaucoma | Posterior Vitreous Detachment | Vitreomacular Traction | Vitreopapillary Traction

Belgium
Allergan

Completed

Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion

Retinal Vein Occlusion | Macular Oedema

Belgium
Bayer
Regeneron Pharmaceuticals

Completed

Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion (RETRO CRVO)

Retinal Vein Occlusion

Belgium
Universitaire Ziekenhuizen KU Leuven

Active, not recruiting

Beovu Experience UZ Leuven (BEL)

Age-Related Macular Degeneration

Belgium
Laurence Postelmans

Completed

Analysis of naïve Patients With Age-related Macular Degeneration of the Neovascular Type and Treated With Aflibercept (Eylea®) in "Treat-and-extend" at CHU Brugmann

Age-related Macular Degeneration

Belgium
Brugmann University Hospital

Completed

Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)

Age-Related Macular Degeneration

Belgium
Brugmann University Hospital

Completed

Effectiveness of Anti-VEGF Treatments in Wet AMD in Active Smokers

Wet Age-related Macular Degeneration

Belgium
Brugmann University Hospital

Completed

Analysis of naïve Patients With Age-related Macular Degeneration Neovascular Type and Treated With Ranibizumab (Lucentis®) in Treat-and-extend at the CHU Brugmann.

Macular Degeneration

Belgium
Brugmann University Hospital

Completed

Impact of the Navilas ® Micropulse Laser Treatment for Macular Edema Within the CHU Brugmann Hospital Macular Edema

Macular Edema

Belgium
Bayer

Completed

A Study Reviewing Medical Records to Learn More About Treat-and-extend With Eylea in Patients With Neovascular Age-related Macular Degeneration (nAMD). (BELUGA)

Neovascular Age-related Macular Degeneration

Belgium
University Hospital, Ghent

Recruiting

Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema

Macular Edema | Retinal Neovascularization

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Visual Outcome After Vitrectomy With Subretinal tPA Injection (EVA-tPA)

Age-Related Macular Degeneration

Belgium
Pfizer

Completed

A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life. (MACURELI)

Neovascular Age-related Macular Degeneration

Belgium
Sheba Medical Center
Universitaire Ziekenhuizen KU Leuven

Unknown

The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD) (AMD)

Neovascular Age Related Macular Degeneration

Belgium, Israel
Universitaire Ziekenhuizen KU Leuven
DORC Dutch Ophthalmic Research Center International BV

Recruiting

Robotic Subretinal tPA Injection Study (RoTIS)

Age-Related Macular Degeneration | Subretinal Hemorrhage

Belgium
Universitaire Ziekenhuizen KU Leuven
Laboratoires Thea

Completed

Omega 3 and Vitamin D Dosage in a Population With Moderate to High Risk of AMD (OVID-AMD)

Age-related Macular Degeneration | Vitamin D Deficiency

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Compare ELP in Patients With Elective Phaco-VTX Surgery in One Eye and a Single Lens Phaco Surgery on the Other Eye (ELP)

Macular Pucker

Belgium
Hasselt University

Unknown

Changes in Microcirculation and Functional Status During Exacerbation of COPD (COPD-EX)

Physical Activity | COPD Exacerbation | Retinal Vascular

Belgium
ThromboGenics

Completed

Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy

Eye Diseases | Vitreomacular Traction Maculopathy

Belgium, Netherlands
Universitaire Ziekenhuizen KU Leuven

Withdrawn

Surgical Stabilizer Assisted RVC With rtPA for CRVO

Central Retinal Vein Occlusion

Belgium
Bayer

Completed

Assessment of Proactive Treatments in Patients With Wet Age-related Macular Degeneration (wAMD) Which Have Never Undergone Treatment of This Particular Disease (XTEND)

Wet Age-related Macular Degeneration

Canada, Spain, Sweden, Belgium, Argentina, Italy, Korea, Republic of, United Kingdom, China, Denmark, France, Norway, Colombia, Australia, Ireland, Switzerland, Thailand
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Completed

Phase I RVC With Ocriplasmin for CRVO (RVC_CRVO)

Central Retinal Vein Occlusion

Belgium
Acusurgical

Recruiting

A Prospective, Open-label, Single-center, Study of the ACUSURGICAL Luca System for Treatment of Vitreoretinal Diseases

Vitreoretinal Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Multimodal Retinal Imaging in the Detection and Follow-up of Alzheimer's Disease (RetAD)

Glaucoma | Age-Related Macular Degeneration | Diabetic Retinopathy | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Alzheimer Dementia

Belgium
Allergan

Completed

Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

Macular Edema

France, Spain, Belgium, United States, South Africa, Denmark, Netherlands, Israel, Portugal, United Kingdom, Italy, Germany
ThromboGenics

Completed

A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME) (MIVI-II)

Diabetic Macular Edema

Spain, Belgium, United Kingdom, Italy, Netherlands, Germany
AbbVie

Recruiting

Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant

Diabetic Macular Edema

Greece, Portugal, Belgium, United Kingdom, Italy, Israel, China, Germany
Novartis

Completed

A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study (RESTORE)

Diabetic Macular Edema

Greece, Belgium, Spain, France, Netherlands, Australia, Canada, Germany, Hungary, Italy, Switzerland, Turkey, United Kingdom
Devogelaere Vision

Completed

Effect of Vitamin Supplementation in Glaucoma Patients

Glaucoma | Homocysteinemia | Elevated Retinal Venous Pressure | Abnormal Steady State Pattern Electroretinography

Belgium
Boehringer Ingelheim

Completed

Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema

Macular Edema

Spain, United Kingdom, Germany, Portugal, France, Belgium, Hungary, Greece
Novartis Pharmaceuticals

Completed

Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD (SALT)

Neovascular Age-related Macular Degeneration

Germany, Austria, Belgium, Denmark, Switzerland, France, Netherlands, Portugal, Sweden, Norway
Maastricht University Medical Center
European Society of Cataract and Refractive Surgeons

Completed

PRevention of Macular EDema After Cataract Surgery (PREMED)

Diabetes Mellitus | Cataract | Cystoid Macular Edema

Netherlands, Austria, Belgium, Germany, Hungary, Portugal, Spain
Novartis Pharmaceuticals

Completed

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting (LUMINOUS)

Diabetic Macular Edema | Retinal Vein Occlusion | Wet Age Related Macular Degeneration | Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion

Spain, China, Colombia, Korea, Republic of, Belgium, Greece, Japan, Russian Federation, Turkey, United Kingdom, Egypt, Germany, Australia, Canada, France, Austria, Hong Kong, Hungary, Israel, Netherlands, Peru, Singapore, Slovakia, Sl... and more
Pfizer

Completed

Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration

Macular Degeneration

Greece, Italy, Slovakia, Spain, Sweden, Czech Republic, Germany, Belgium, France, Cyprus, Denmark, Ireland, Poland
Oxurion

Completed

A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME)

Diabetes Mellitus | Diabetic Retinopathy | Macular Edema

France, United Kingdom, Belgium, Spain, Germany, Slovakia, Switzerland
Erasme University Hospital

Unknown

Study of Catheter Based Renal Denervation Therapy in Hypertension (DEPART)

Renal Function | Resistant Hypertension | Ambulatory Blood Pressure | Renal Denervation

Belgium
GlaxoSmithKline

Completed

To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD

Macular Degeneration

Italy, United States, Belgium, Australia
GlaxoSmithKline

Completed

Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration

Macular Degeneration

United States, Australia, Italy, Belgium, Germany, Canada, Japan, Sweden, Denmark
Novartis Pharmaceuticals

Completed

To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema

Macular Edema (ME)

Russian Federation, Turkey, United Kingdom, Belgium, Australia, Hungary, Switzerland, Germany, Italy, Korea, Republic of, Israel, Spain, France, Latvia, Netherlands, Slovakia, Czech Republic, Singapore, Canada
ThromboGenics

Completed

Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion (MIVI-5)

Exudative Age-Related Macular Degeneration | Focal Vitreomacular Adhesion

United States, United Kingdom, Germany, France, Belgium, Italy
Hoffmann-La Roche

Recruiting

A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

Neovascular Age-related Macular Degeneration (nAMD)

Belgium, Korea, Republic of, Germany, Spain, United Kingdom, Australia, Italy, Argentina, Israel, Austria, Brazil, France, Singapore, Switzerland, Taiwan, Turkey
Novartis Pharmaceuticals

Completed

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study (TALON Ext)

Neovascular Age-related Macular Degeneration

United States, Czechia, Italy, Taiwan, Australia, Israel, Belgium, France, Spain, Germany, Korea, Republic of, Portugal, Sweden, Netherlands, Malaysia, Switzerland
Hoffmann-La Roche

Recruiting

Extension Study for the Port Delivery System With Ranibizumab (Portal) (Portal)

Neovascular Age-Related Macular Degeneration

Belgium, United States, United Kingdom, Italy, Argentina, Spain, Israel, Australia, Austria, Brazil, Germany, Switzerland, Taiwan, France
Ophthotech Corporation

Terminated

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Age-Related Macular Degeneration

Italy, Canada, Switzerland, United States, United Kingdom, Austria, Belgium, Brazil, Czechia, Estonia, Latvia, Poland, Slovakia
Chengdu Kanghong Biotech Co., Ltd.

Terminated

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1)

Neovascular Age-related Macular Degeneration

United States, Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Germany, Hong Kong, Lithuania, Mexico, Netherlands, New Zealand, Peru, Philippines, Poland, Portugal, Singapore, Spain, Switzerland, Taiwan
Novartis

Terminated

Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

Macular Degeneration | Choroidal Neovascularization

United Kingdom, Spain, Netherlands, Hungary, Italy, Denmark, Belgium, Austria, France, Germany, Poland, Switzerland
Fovea Pharmaceuticals SA

Completed

Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy

Diabetic Macular Edema

United States, Australia, Belgium, Czech Republic, France, Germany, Israel, Italy, Poland, Spain
Novartis Pharmaceuticals

Completed

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON) (TALON)

Age-related Macular Degeneration

United States, Austria, Czechia, Italy, Taiwan, Belgium, Germany, Australia, Israel, Canada, France, Spain, Korea, Republic of, United Kingdom, Portugal, Netherlands, Sweden, Argentina, Malaysia, Switzerland

Clinical Trials on Macular Hole Retinal Detachment in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations